"An HIV vaccine has escaped the innovative scientific community with good reason: the HIV virus is both complicated and evasive....Yet, recent clinical trials of an mRNA vaccine offered promising early-stage results. June marked the 40 th anniversary of the first reported AIDS case. On the anniversary, UNAIDS released a strategy to end HIV/AIDS by 2030, a goal that seemed unthinkable over 40 years ago. Yet since 1981, the innovative scientific community has delivered a series of treatments that revolutionized the outlook for HIV/AIDS patients."
"Those early days of 1981 were not unlike what we experienced with coronavirus last spring. Hospitals began to see cases of a mysterious pneumonia with few options for how to treat it, just as physicians across the country struggled to identify effective treatments for COVID-19 patients last March. Indeed, Dr. Anthony Fauci - who dedicated 40 years of his career to combatting HIV/AIDS - recalled "the first few years were the darkest years of my medical career, because I was working countless hours taking care of desperately ill young men.""
"In the 1980s and 1990s, just as it did through the COVID-19 pandemic, the science delivered solutions to help get us through the darkest days. By 1986, the innovative community discovered the first therapy that could be used effectively to combat HIV with AZT, though it was not without limitations. Scientists quickly learned that the virus rapidly developed resistance to the treatment, rendering it less effective than initially hoped."
June marked the 40th anniversary of the first reported AIDS case and UNAIDS released a strategy to end HIV/AIDS by 2030. Early epidemic years resembled initial COVID-19 uncertainty, with mysterious pneumonia cases and limited treatment options. In 1986 AZT became the first effective therapy but the virus rapidly developed resistance. Continued incremental innovation reduced pill burdens from 28 pills a day to one and produced PrEP, which cuts infection risk by 99%. Recent clinical trials of mRNA vaccines have shown promising early-stage results, sustaining progress toward better prevention and treatment.
Read at IPWatchdog.com | Patents & Intellectual Property Law
Unable to calculate read time
Collection
[
|
...
]